scispace - formally typeset
N

Nicola Maffulli

Researcher at University of Salerno

Publications -  1759
Citations -  68924

Nicola Maffulli is an academic researcher from University of Salerno. The author has contributed to research in topics: Medicine & Achilles tendon. The author has an hindex of 115, co-authored 1570 publications receiving 59548 citations. Previous affiliations of Nicola Maffulli include University of Aberdeen & University of Sydney.

Papers
More filters
Journal ArticleDOI

Dorsally Based Closing Wedge Osteotomy of the Calcaneus for Insertional Achilles Tendinopathy

TL;DR: The modified dorsal closing wedge calcaneal osteotomy is a safe procedure and significantly improved pain and function in patients with IAT at 2 years after surgery.
Journal ArticleDOI

Minimally Invasive Surgery for Achilles Tendon Pathologies

TL;DR: This work presents the recent advances in the field of minimally invasive AT surgery for tendinopathy, acute ruptures, chronic tears, and chronic avulsions of the Achilles tendon.
Journal ArticleDOI

Correlation between time from injury to surgery and the prevalence of ramp and hidden lesions during anterior cruciate ligament reconstruction. A new diagnostic algorithm.

TL;DR: The diagnostic algorithm described is a valid and safe option to diagnose Ramp and hidden lesions are very common ACL rupture associated injuries and a correlation between a longer time from injury than 6 months and a reduced prevalence of these lesions was recorded in the population.
Journal ArticleDOI

Stem Cell and Macrophage Roles in Skeletal Muscle Regenerative Medicine.

TL;DR: In this paper, the authors summarize current knowledge on functions of stem cells and macrophages in skeletal muscle repairs and their roles as components of a promising cell-based therapies for muscle repair and regeneration.
Journal ArticleDOI

Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review

TL;DR: In this article, the potential of these biomarkers in predicting the clinical outcomes in terms of BMD, t-score, rate of fractures, and adverse events during the therapy setting in postmenopausal osteoporosis was analyzed.